Today: 7 February 2026
Subscribe
Browse Category

IPO News News 17 December 2025 - 27 December 2025

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

NEW YORK, Dec. 27, 2025, 4:10 p.m. ET — Market Closed (Weekend) Medtronic plc (NYSE: MDT) heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run. With U.S. markets shut until Monday’s open, the immediate question for shareholders isn’t what MDT did minute-to-minute on Saturday—because it didn’t trade—but what the stock’s latest positioning says about sentiment, and what
27 December 2025
···
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

December 22, 2025 — Barrick Mining Corporation stock is ending the year with a rare triple tailwind: a fresh record in gold prices, a major geopolitical overhang easing in Mali, and an ongoing strategic shake-up that could materially change how the market values the company’s North American assets. Gold pushed through $4,400 per ounce for the first time on Monday, underscoring why miners have suddenly become the financial markets’ unlikely main characters again—part inflation hedge, part “rates are coming down” trade, part geopolitical insurance policy. Reuters For Barrick (ticker B in New York and ABX in Toronto), that commodity backdrop
22 December 2025
···
Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Limited’s newly listed stock is doing what freshly public, hotly debated consumer-tech names often do: sprint, stumble, then dare investors to tell a coherent story about what “fair value” even means. On Monday, December 22, 2025, Meesho shares were trading around ₹209–₹212 by midday, down roughly 6–7% versus the prior close, after an eye-catching post-IPO surge that briefly pushed the company’s market cap toward (and in prior sessions above) the ₹1 trillion milestone. Business Standard+2Moneycontrol+2 Below is a full roundup of the current news, forecasts, and market analysis as of 22.12.2025—from the latest selloff narrative to brokerage targets, trading
22 December 2025
··
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

Mumbai/Bengaluru — December 21, 2025 — The National Stock Exchange of India (NSE) is ending 2025 in a situation that would have sounded contradictory a few years ago: India is home to one of the biggest derivatives machines on Earth, yet the country’s flagship equity market is behaving like it’s on sedatives. Options traders are being forced to rethink playbooks, regulators are still tightening the screws on speculation, and the exchange itself remains in the spotlight for a long-awaited IPO that’s still gated by settlements and governance clean-up. Because December 21, 2025 is a Sunday (markets are shut), the day’s
21 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of U.S. drug-pricing headlines that could reshape sentiment into 2026. Investopedia+4Reuters+4Reuters+4 The setup matters because next week’s market structure will be unusual: U.S. stock markets are scheduled to close early on Wednesday, December 24 (1:00 p.m. ET) and remain closed on
21 December 2025
·····
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Stock Exchange (SSE) heads into the final full trading stretch of 2025 with two stories unfolding at once: a steadier, policy-sensitive main board and a turbo-charged STAR Market where “hard tech” listings—especially AI chipmakers—are setting the tone for risk appetite. As of Sunday, Dec. 21 (when the mainland market is closed), the latest official close for the benchmark Shanghai Composite Index is Friday’s session, when it rose 0.36% to 3,890.45. Xinhua News Shanghai Composite ends the week flat, with investors waiting for fresh signals Friday’s uptick helped steady the market after choppy trading earlier in the week. Reuters’
21 December 2025
·
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Ltd (NSE: RELIANCE; BSE: 500325) heads into the final stretch of 2025 with its stock trading close to a fresh 52-week peak—powered by a familiar Reliance cocktail: strong refining economics, rising confidence in consumer-facing cash flows, and a growing “value-unlocking” narrative around Jio. LiveMint+2Investing.com+2 RIL shares closed Friday, December 19, at ₹1,565.10, leaving the stock roughly 1% below the 52-week high around ₹1,581. The rally has been meaningful: Reliance is up about 28% year-to-date in 2025, comfortably outpacing the benchmark Sensex over the same period. LiveMint+1 What’s driving the renewed attention is not just price momentum—it’s the pile-up
21 December 2025
····
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

NEW YORK, Dec. 19, 2025 — Morgan Stanley stock (NYSE: MS) traded higher Friday as investors weighed a cluster of catalysts: a Reuters report that the bank is emerging as a leading candidate to help run a potential SpaceX initial public offering, a drumbeat of upbeat industry outlooks for 2026 dealmaking, and a growing focus on Morgan Stanley’s upcoming fourth-quarter results in mid-January. Reuters+2Nasdaq+2 Shares were last indicated around $176.87, up about 2.3% on the session, with trading ranging from roughly $173.07 to $177.54 intraday, according to market data. The move comes after a soft patch earlier in the week.
19 December 2025
···
Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

December 19, 2025 — Navan, Inc. (NASDAQ: NAVN) stock is sharply higher in Friday trading, putting the newly public corporate travel-and-expense platform back on traders’ screens just days after its debut earnings report triggered a steep selloff. The immediate catalyst: a notable open-market insider purchase disclosed in an SEC filing, which helped shift the day’s narrative from “post‑earnings pain” to “insider conviction.” SEC+1 As of late morning New York time, Navan stock traded around $15.27, up about 11% on the day. Even with today’s rebound, NAVN remains well below its $25 IPO price, a reminder that the market is still
19 December 2025
···
Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. (Nasdaq: MDLN) is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 (down 2.49% on the day) and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing.com The timing matters: today wasn’t just “day two volatility.” Medline also officially closed its upsized IPO and confirmed that underwriters fully exercised their option for additional shares—an update that helps investors understand near-term share supply, stabilization mechanics, and how quickly the
18 December 2025
··
Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Updated: December 18, 2025 — Gujarat Kidney and Super Speciality Ltd has finalised the price band for its upcoming mainboard IPO, setting the stage for a ₹251 crore public issue that will open next week. The offer is entirely a fresh issue—meaning the company (not selling shareholders) will receive the proceeds—at a time when investors are tracking healthcare listings closely for both growth visibility and execution risks. The Economic Times+1 Gujarat Kidney and Super Speciality IPO: price band, dates, and key application details The company has fixed the IPO price band at ₹108–₹114 per equity share. The public issue is
18 December 2025
·
Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Updated: 4:40 PM ET (Dec. 17, 2025) The Nasdaq Stock Market closed sharply lower on Wednesday as renewed anxiety around the “AI trade” hit megacap technology and chip leaders, sending the Nasdaq Composite down 418.14 points (-1.81%) to 22,693.32—a three-week low—despite a headline-grabbing IPO debut on the exchange and a late-day after-hours surge in Micron following blockbuster guidance. Reuters+2AP News+2 Below is what moved the Nasdaq today, what analysts are watching next, and the key forecasts shaping expectations into year-end and 2026. Nasdaq closes at 22,693 as tech leads a broad risk-off move After a brief early lift, selling accelerated through the
17 December 2025
····
1 2 3 4 5 6 … 10

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop